Search Results - "Miehsler, W."

Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism? by Miehsler, W, Reinisch, W, Valic, E, Osterode, W, Tillinger, W, Feichtenschlager, T, Grisar, J, Machold, K, Scholz, S, Vogelsang, H, Novacek, G

“…Background: Patients with inflammatory bowel disease (IBD) are thought to be at increased risk of venous thromboembolism (TE). However, the extent of this risk…”
Get full text

Effect of virtual endoscopy simulator training on performance of upper gastrointestinal endoscopy in patients: a randomized controlled trial by Ferlitsch, A, Schoefl, R, Puespoek, A, Miehsler, W, Schoeniger-Hekele, M, Hofer, H, Gangl, A, Homoncik, M

“…Skills in gastrointestinal endoscopy mainly depend on experience and practice. Patients upon whom trainees perform their first endoscopic examinations are…”
Get more information

Antibiotics and azathioprine for the treatment of perianal fistulas in Crohn's disease by Dejaco, C., Harrer, M., Waldhoer, T., Miehsler, W., Vogelsang, H., Reinisch, W.

“…Summary Background : Antibiotics and thiopurines have been employed in the management of fistulizing Crohn's disease, although evidence of their efficacy is…”
Get full text

A decade of infliximab: The Austrian evidence based consensus on the safe use of infliximab in inflammatory bowel disease by Miehsler, W, Novacek, G, Wenzl, H, Vogelsang, H, Knoflach, P, Kaser, A, Dejaco, C, Petritsch, W, Kapitan, M, Maier, H, Graninger, W, Tilg, H, Reinisch, W

“…Infliximab (IFX) has tremendously enriched the therapy of inflammatory bowel diseases (IBD) and other immune mediated diseases. Although the efficacy of IFX…”
Get full text

An open‐label trial of the selective cyclo‐oxygenase‐2 inhibitor, rofecoxib, in inflammatory bowel disease‐associated peripheral arthritis and arthralgia by Reinisch, W., Miehsler, W., Dejaco, C., Harrer, M., Waldhoer, T., Lichtenberger, C., Vogelsang, H.

“…Summary Background: Conventional non‐steroidal anti‐inflammatory drugs have been associated with an increased risk of exacerbation of inflammatory bowel…”
Get full text

Colorectal cancer: screening and surveillance in inflammatory bowel diseases - consensus of the working group for inflammatory bowel diseases of the Austrian Society of Gastroenterology and Hepatology by Angelberger, S, Campregher, C, Fuchssteiner, H, Gasche, C, Gröchenig, H-P, Haas, T, Kazemi-Shirazi, L, Mayer, A, Miehsler, W, Platzer, R, Reinisch, W, Steiner, P, Tilg, H, Tillinger, W, Vogelsang, H, Novacek, G

“…Patients with ulcerative colitis and Crohn's colitis are at increased risk of colorectal cancer (CRC). This risk is dependent on the duration and extent of…”
Get more information

Infliximab therapy for Crohn's disease - a practical guideline: actualised consensus of the working group for chronic inflammatory bowel diseases of the Austrian Society for Gastroenterology and Hepatology by Reinisch, W, Dejaco, C, Feichtenschlager, T, Haas, T, Kaser, A, Miehsler, W, Novacek, G, Petritsch, W, Platzer, R, Tilg, H, Vogelsang, H, Knoflach, P

“…Infliximab is a monoclonal antibody against tumor necrosis factor alpha (TNF-α), which is approved for the treatment of chronic inflammatory bowel disease…”
Get more information

Thromboembolism and resistance to activated protein C in patients with inflammatory bowel disease by Novacek, Gottfried, Miehsler, Wolfgang, Kapiotis, Stylianos, Katzenschlager, Reinhold, Speiser, Wolfgang, Vogelsang, Harald

“…Thromboembolic events are serious complications in patients with inflammatory bowel disease (IBD). Resistance of factor V to degradation by activated protein C…”
Get full text

Impact of depressive mood on relapse in patients with inflammatory bowel disease: a prospective 18-month follow-up study by Mittermaier, Christian, Dejaco, Clemens, Waldhoer, Thomas, Oefferlbauer-Ernst, Anna, Miehsler, Wolfgang, Beier, Markus, Tillinger, Wolfgang, Gangl, Alfred, Moser, Gabriele

“…There is evidence of an interaction between psychological factors and activity of inflammatory bowel disease (IBD). We examined the influence of depressive…”
Get full text

P308 The need for psychological and psychotherapeutic interventions in Austrian patients with inflammatory bowel disease by Kutschera, M, Waldhör, T, Gröchenig, H P, Haas, T, Wenzl, H, Steiner, P, Koch, R, Feichtenschlager, T, Eckhardt, G, Mayer, A, Kirchgatterer, A, Ludwiczek, O, Platzer, R, Papay, P, Gartner, J, Fuchssteiner, H, Peters, P G, Reicht, G, Moser, G, Dejaco, C, Primas, C, Novacek, G, Miehsler, W

“…Abstract Background inflammatory bowel diseases (IBD) are lifelong conditions challenging the patient not only with respect to somatic complaints but also…”
Get full text

Mechanic intestinal obstruction--a possible presentation of perforated appendicitis by Miehsler, W, Wunderbaldinger, P, Novacek, G, Teleky, B, Wrba, F, Penner, E, Gangl, A

“…A 61-year-old man presented with diffuse abdominal pain, diarrhea, vomiting and fever. On the initial diagnosis of gastroenteritis the patient received the…”
Get more information

P695 Does anticoagulation treatment increase the rate of major bleeding complications in patients with IBD and venous thromboembolism? by Novacek, G, Tonko, S, Sobala, A, Tilg, H, Petritsch, W, Reinisch, W, Mayer, A, Haas, T, Ludwiczek, O, Feichtenschlager, T, Fuchssteiner, H, Steiner, P, Vogelsang, H, Miehsler, W, Platzer, R, Tillinger, W, Schmid, A, Blaha, B, Herkner, H

“…Abstract Background Patients with inflammatory bowel disease (IBD) are at increased risk of first and recurrent venous thromboembolism (VTE). Anticoagulation…”
Get full text

P352 Is diagnostic delay associated with the risk of colectomy in patients with ulcerative colitis? Results of a study of the Austrian IBD study group by Novacek, G, Gröchenig, H P, Haas, T, Wenzl, H, Steiner, P, Koch, R, Feichtenschlager, T, Eckhardt, G, Mayer, A, Kirchgatterer, A, Ludwiczek, O, Platzer, R, Papay, P, Gartner, J, Fuchssteiner, H, Miehsler, W, Peters, P, Reicht, G, Vogelsang, H, Dejaco, C, Waldhör, T

“…Abstract Background Long diagnostic delay is frequent in inflammatory bowel disease and has been described to be associated with an increased risk for…”
Get full text

P233 Diagnostic delay in a large cohort of patients with inflammatory bowel disease – results of a multicenter study of the Austrian IBD Study Group (ATISG) by Novacek, G., Gröchenig, H.P., Waldhör, T., Eckhardt, G., Feichtenschlager, T., Haas, T., Kirchgatterer, A., Koch, R., Ludwiczek, O., Mayer, A., Miehsler, W., Papay, P., Peters, P., Platzer, R., Reicht, G., Steiner, P., Wenzl, H., Fuchssteiner, H., Gartner, J., Vogelsang, H., Dejaco, C.

Get full text

Impact of real-time continuous glucose monitoring on glucose variability in critically ill patients by Brunner, R, Kitzberger, R, Miehsler, W, Fuhrmann, V, Madl, C, Holzinger, U

Get full text

Is mycophenolate mofetil an effective alternative in azathioprine-intolerant patients with chronic active Crohn's disease? by Miehsler, Wolfgang, Reinisch, Walter, Moser, Gabriele, Gangl, Alfred, Vogelsang, Harald

“…Up to 50% of patients with Crohn's disease (CD) develop steroid-dependent or refractory disease requiring immunosuppression. Azathioprine (AZA) is usually used…”
Get full text

Prevalence and clinical importance of hypertransaminasaemia in coeliac disease by Novacek, G, Miehsler, W, Wrba, F, Ferenci, P, Penner, E, Vogelsang, H

“…To assess the prevalence and potential pathogenetic factors of hypertransaminasaemia in patients with coeliac disease prior to initiation of a gluten-free diet…”
Get more information

A prospective, open-label trial of 6-thioguanine in patients with ulcerative or indeterminate colitis by TEML, Alexander, SCHWAB, Matthias, HARRER, Marieluise, MIEHSLER, Wolfgang, SCHAEFFELER, Elke, DEJACO, Clemens, MANTL, Martina, SCHNEIDER, Barbara, VOGELSANG, Harald, REINISCH, Walter

“…6-thioguanine (6-TG) has emerged as a promising therapeutic alternative in patients with Crohn's disease intolerant or resistant to azathioprine (AZA) and/or…”
Get full text

Do high serum levels of anti-Saccharomyces cerevisiae antibodies result from a leakiness of the gut barrier in Crohn's disease? by Harrer, Marieluise, Reinisch, Walter, Dejaco, Clemens, Kratzer, Verena, Gmeiner, Maria, Miehsler, Wolfgang, Norman, Gary L, Gangl, Alfred, Vogelsang, Harald

“…OBJECTIVESTo examine the relationship between serum levels of anti-Saccharomyces cerevisiae antibodies (ASCAs) and intestinal permeability at a given time…”
Get full text

12 - Immunosuppressive (IS) therapy impacts the results of Quantiferon® and tuberculin skin test in routine screening for latent tuberculosis (LTB) in patients with inflammatory bowel diseases (IBD) by Papay, P., Eser, A., Miehsler, W., Lichtenberger, C., Mikulits, A., Dejaco, C., Novacek, G., Vogelsang, H., Reinisch, W.

Get full text